Treating Low Back Pain without Opioids Activity
Release Date: May 29, 2018
Expiration Date: May 29, 2019
This educational activity is provided by Dannemiller
Supported by an educational grant from Pfizer.
Physicians, pain specialists, chiropractors, physical therapists, nurse practitioners and other health care professionals with an interest in treating acute non-specific lower back pain.
Upon completion of this activity, the participant should be able to:
- Describe the role of non-pharmacologic management of acute lower back pain in the first-line setting.
- Integrate thermal heat-based therapy into management plans for patients with acute low-back pain.
- Discuss other evidence-based non-pharmacologic and noninvasive methods for treatment of acute low-back pain, including acupuncture, physical therapy and massage, and injections.
Statement of Need
Low-back pain is a common and disabling condition, with most individuals experiencing low-back pain at some point in their lives. In terms of overall worldwide burden, low-back pain ranked sixth out of the 291 conditions evaluated. The high disability linked to low-back pain is likely correlated with the increasing global prevalence, with 9.4% of the population experiencing back pain, translating to 83 million people in 2010. This proposed educational initiative will inform clinicians about the most recent guidelines and detail the nonpharmacologic solutions in a hierarchical model, intended to provide clinicians with the tools to appropriately manage acute low-back pain.
Method of Participation
This activity should take approximately 45 minutes to complete. Participants should first read the objectives and other introductory CME/CE information and then proceed to the educational activity. To receive credit for this activity, participants must complete the post-test with a passing score of 80% and then complete the evaluation. Credit is provided through May 31, 2019. No credit will be given after this date. There is no fee to participate in this activity.
In the event you have questions about this activity or are unable to retrieve the certificate, please email firstname.lastname@example.org and a certificate will be emailed within 2 weeks.
- Computer, tablet, or smartphone with internet access
- HTML5 compatible browser or Adobe Flash Player
In support of improving patient care, Dannemiller is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Dannemiller designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Physician assistants may receive a maximum of 0.75 AMA PRA Category 1 Credit(s)™ for completing this program.
Dannemiller is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners: AANP Provider Number 090419. This program was planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standards. It provides 0.75 contact hours of continuing education.
Paul J. Christo, M.D., M.B.A.
Department of Anesthesiology and Critical Care Medicine
Division of Pain Medicine
The Johns Hopkins University School of Medicine
Jeannette Anderson, D.C. - Anderson Peak Performance
Lora Lee Alves, MSEd, LAc - Acupuncturist
Amber Bloom, PT, MSPT - Physical Therapist
Shea Davies - Massage Therapist
In accordance with the Accreditation Council for Continuing Medical Education (ACCME), Dannemiller requires that any person who is in a position to control the content of a CME/CE activity must disclose all financial relationships they have with a commercial interest.
The following faculty have financial relationships with commercial interests: Paul Christo, MD, MBA: Advisory/Medical Board – GlaxoSmithKline.
Jeannette Anderson, D.C.; Lora Lee Alves, MSEd, LAc; Amber Bloom, PT, MSPT; Shea Davies; Scott Courtney, Audio Video; Jennifer Hodge, Dannemiller Project Manager; Linda Alvers, RN, MSN, have no financial relationships with commercial interests.
To resolve identified/potential conflicts of interest, the educational content was fully reviewed by a member of the Dannemiller Clinical Content Review Committee who has nothing to disclose. The resulting certified activity was found to provide educational content that is current, evidence based and commercially balanced.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Dannemiller. This material is prepared based upon a review of multiple sources of information, but it is not exhaustive of the subject matter. Therefore, healthcare professionals and other individuals should review and consider other publications and materials on the subject matter before relying solely upon the information contained within this educational activity.